2018
DOI: 10.3389/fmed.2018.00060
|View full text |Cite
|
Sign up to set email alerts
|

Echinococcus granulosus: Cure for Cancer Revisited

Abstract: Whereas a number of parasites are well recognized risk factors for a number of different cancers in mammalian hosts, there is limited information on the ability of parasitic organisms to induce anticancer effects. There are conflicting reports that echinococcosis, caused by the canine tapeworm Echinococcus granulosus, can decrease or increase cancer risk. This review considers both indirect anticancer effects as the result of adaptive immunity generated against certain echinococcal antigens and the direct effe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0
3

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(10 citation statements)
references
References 42 publications
(49 reference statements)
0
7
0
3
Order By: Relevance
“…Other researchers observed the direct effect of molecules released by Echinococcus granulosus whose activity directly inhibits cancer cell migration and growth. These authors concluded that E. granulosus probably secretes molecules that can develop as anti-cancer therapeutics in the future [11].…”
Section: The "Cancer Hygiene Hypothesis" Explainedmentioning
confidence: 99%
“…Other researchers observed the direct effect of molecules released by Echinococcus granulosus whose activity directly inhibits cancer cell migration and growth. These authors concluded that E. granulosus probably secretes molecules that can develop as anti-cancer therapeutics in the future [11].…”
Section: The "Cancer Hygiene Hypothesis" Explainedmentioning
confidence: 99%
“…E. granulosus is still highly epidemic in South America, Mediterranean countries, eastern Africa, Central Asia, and Northwestern China, with human incidence as high as 50 per 100,000 person-years according to a report from the World Health Organization (Brunetti et al, 2010). However, after the astonishingly low incidence of CE was incidentally found in patients with solid tumor in Turkey (Akgül et al, 2003), accumulating evidence have suggested that E. granulosus may exhibit anticancer effect through host immune system, which may be employed as an immunotherapeutic strategy against cancer (Ranasinghe and McManus, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…Subsequently, another study found that injection of hydatid fluid (peritoneal or tumor margin) could decrease melanoma tumor size in C57 mouse model (Darani et al, 2016). However, the alum-based adjuvant employed in the latter study is potentially confounding (Ranasinghe and McManus, 2018), since alum may induce anticancer effect through selectively stimulation of Th2 immune response (Didierlaurent et al, 2009). Recently, a research group found that the Kunitz-type protease inhibitor EgKI-1, a potent chymotrypsin and neutrophil elastase inhibitor highly expressed by oncosphere of E. granulosus (Ranasinghe et al, 2015), could inhibit several human cancers from growth and migration, probably through disrupting cell cycle and inducing apoptosis of cancer cells, without affecting normal cell growth in vitro (Ranasinghe et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…It is hypothesized that this parasite elicits a protective effect against cancer due to antigenic similarities between components of hydatid cysts and cancer cells [100]. Moreover, in the acute and chronic phases of infection, oncospheres and hydatid cysts release Kunitz-type protease inhibitors (EgKI-1) and B antigen (Table S1), which inhibit neutrophil chemotaxis, and neutrophil-associated elastase, which affects the cell cycle [60,101,102]. Furthermore, the release of mucin-type O-glycan activates the innate and Th1 responses against cancer [60,100].…”
Section: Echinococcus Granulosusmentioning
confidence: 99%